The impact of Parkinson's disease as a comorbid diagnosis

3Citations
Citations of this article
18Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Clinicians, departments and trusts are compared using Hospital Standardised Mortality Ratios. The benchmarking process makes corrections for patients' past medical histories, using a tool called the Charlson Index of Co-morbidity. Patients with any of 17 conditions receive an adjustment to their expected mortality and length of stay. Although the weighting of these conditions has been altered to take account of advances in medical practice, there have been no conditions added to the list since Charlson's original paper of 1986. The Charlson Index of Co-morbidity does not make a correction for Parkinson's disease. We describe evidence of the impact of Parkinson's disease as a co-morbid condition and recommend that, in future, benchmarking processes should take account of this important and common diagnosis. © The Author 2011. Published by Oxford University Press on behalf of the British Geriatrics Society. All rights reserved.

Cite

CITATION STYLE

APA

Phillips, A. R., & Genever, R. W. (2011). The impact of Parkinson’s disease as a comorbid diagnosis. Age and Ageing, 40(3), 294–296. https://doi.org/10.1093/ageing/afr022

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free